Evidence map›Paper›PMID 31482953›Full record

ArticleArchives of endocrinology and metabolism2019

Thyroid nodules ≤ 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinion.

Pedro Weslley Rosario, Laura Sterian Ward, Hans Graf, Fernanda Vaisman, Gabriela Franco Mourão, Mario Vaisman

Abstract read
In one paragraph

Article in Archives of endocrinology and metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Active surveillance of thyroid microcarcinomas.Archives of endocrinology and metabolism · 2019
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Pedro Weslley RosarioSanta Casa de Belo Horizonte, Minas Gerais, MG, Brasil.ORCID http://orcid.org/0000-0002-5190-382X
Laura Sterian WardFaculdade de Ciências Médicas da Universidade Estadual de Campinas (Unicamp), São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0003-3553-5358
Hans GrafUniversidade Federal do Paraná (UFPR), Curitiba, PR, Brasil.ORCID http://orcid.org/0000-0001-8671-1556
Fernanda VaismanUniversidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0002-6835-7108
Gabriela Franco MourãoSanta Casa de Belo Horizonte, Minas Gerais, MG, Brasil.ORCID http://orcid.org/0000-0003-0916-3490
Mario VaismanUniversidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0002-9469-4298

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The indolent evolution of low-risk papillary thyroid microcarcinoma (mPTC) in adult patients and the consequences of thyroidectomy require a revision of the management traditionally recommended. Aiming to spare patients unnecessary procedures and therapies and to optimize the health system in Brazil, we suggest some measures. Fine-needle aspiration of nodules ≤ 1 cm without extrathyroidal extension on ultrasonography should be performed only in nodules classified as "very suspicious" (i.e., high suspicion according to ATA, high risk according to AACE, TI-RADS 5) and in selected cases [age < 40 years, nodule adjacent to the trachea or recurrent laryngeal nerve (RLN), multiple suspicious nodules, presence of hypercalcitoninemia or suspicious lymph nodes]. Active surveillance (AS) rather than immediate surgery should be considered in adult patients with low-risk mPTC. Lobectomy is the best option in patients with unifocal low-risk mPTC who are not candidates for AS because of age, proximity of the tumor to the trachea or RLN, or because they opted for surgery. The same applies to patients who started AS but had a subsequent surgical indication not due to a suspicion of tumor extension beyond the gland or multicentricity. Molecular tests are not necessary to choose between AS and surgery or, in the latter case, between lobectomy and total thyroidectomy. The presence of RAS or other RAS-like mutations or BRAFV600E or other BRAF V600E-like mutations should not modify the management cited above; however, the rare cases of mPTC exhibiting high-risk mutations, like in the TERT promoter or p53, are not candidates for AS.

Indexed as

Biopsy, Fine-NeedleCarcinoma, PapillaryExpert TestimonyHumansThyroidectomyThyroid NeoplasmsThyroid Nodule

Identifiers

PMID31482953
PMCPMC10522266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.